ULGX

UROLOGIX INC by Urologix, Inc. (ULGX)

About UROLOGIX INC by Urologix, Inc. (ULGX)

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company was founded by Mitchell Dann and John M. Reid on May 29, 1991 and is headquartered in Minneapolis, MN.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.00
Market cap
2,200
Dividend yield
0.00%
Volume
--
Avg. volume
537
P/E ratio
--

UROLOGIX INC by Urologix, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.04
52 Week Low
$0.00
Market cap
2,200
Dividend yield
0.00%
Volume
--
Avg. volume
537
P/E ratio
--